Zhu, Hai-Dong
Li, Xiao
Ji, Jian-Song
Huang, Ming
Shao, Guo-Liang
Lu, Jian
Zhao, Xu-Ya
Li, Hai-Liang
Yang, Zheng-Qiang
Tu, Jian-Fei
Zhou, Jin-Mei
Zeng, Chu-Hui
Teng, Gao-Jun https://orcid.org/0000-0001-5800-3640
Funding for this research was provided by:
Beijing Suopuxingda Pharmaceutical Research Co., Ltd
Article History
Received: 15 February 2022
Revised: 14 April 2022
Accepted: 26 April 2022
First Online: 1 July 2022
Declarations
:
: The authors declare no competing interests.
: Written informed consent was obtained from all trial participants included in the study.
: Institutional Review Board approval was obtained.
: • Prospective• Interventional• Performed at seven institution